Jing-Shyh (Sam) Su resigned as Director at BeOne Medicines Ltd..
“On January 31, 2022, Jing-Shyh (Sam) Su resigned from the Board of Directors (the “Board”) of BeiGene, Ltd. (the “Company”).”
BeOne Medicines Ltd. — fact timeline
Source-grounded facts extracted from BeOne Medicines Ltd.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Howard Liang retired as Chief Financial Officer and Chief Strategy Officer at BeOne Medicines Ltd..
“On June 30, 2021, Howard Liang, Ph.D., Chief Financial Officer and Chief Strategy Officer, retired from the Company.”
Julia Wang was appointed as Chief Financial Officer at BeOne Medicines Ltd..
“on June 30, 2021, Julia Wang became the Chief Financial Officer of BeiGene, Ltd.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.